Candida albicans is a major fungal pathogen that causes mucosal and systemic infections in immunocompromised hosts. A key factor in the virulence of C. albicans is its ability to switch from a yeast to a hyphal form while inside a host. This switch has been implicated in the pathogenesis of systemic C. albicans infections, because mutants with defective hyphal growth show reduced virulence (Lo et al., 1997; Jacobsen et al., 2012) . The hyphal form of C.
albicans is able to use hemoglobin as a source of iron, suggesting that this is an important factor in the switch to the hyphal form and in injury to the host. Because hemoglobin promotes true hyphal morphogenesis, hemoglobin utilization is considered a virulence factor (Tanaka et al., 1997; Pendrak & Roberts, 2007) .
Candida albicans has three main systems for acquiring iron: a reductive system, a siderophore uptake system, and a heme iron uptake system. The reductive pathway involves the release of iron from transferrin or ferritin or the exploitation of free iron in the environment. The glycosylphosphatidylinositol (GPI)-anchored cell-wall protein Als3 is a receptor for ferritin in the host environment (Almeida et al., 2009) . Candida albicans does not secrete siderophores, which are high-affinity iron chelators, to scavenge iron, but instead it takes up siderophores synthesized by other microorganisms via the Sit1 transporter (Heymann et al., 2002) . Independent of these two iron uptake systems, C. albicans is also capable of taking up iron from hemoglobin and hemeproteins through a process of erythrocyte lysis, hemoglobin binding, heme extraction, and endocytosis (Manns et al., 1994; Weissman & Kornitzer, 2004) . It has been suggested that the members of the C. albicans heme-receptor protein family that possess the CFEM (Common in Several Fungal Extracellular Membranes) domain (i.e., Csa1, Csa2 and Pga7 [Rbt6], Rbt5, and Rbt51
[Pga10]) are involved in this third system of iron uptake (Weissman & Kornitzer, 2004) .
Unlike the other CFEM-containing proteins, which are attached to both the cell wall and the plasma membrane, the small, secretory protein Csa2 does not possess a GPI anchor (Sosinska et al., 2008; Weissman et al., 2008; Sorgo et al., 2010 Sorgo et al., , 2011 . Transcriptional studies have indicated that several cell wall proteins are regulated by iron availability, and that the increased expression of CFEM-containing proteins in conditions of iron starvation supports their involvement in iron acquisition (Lan et al., 2004; Chen et al., 2011) . The precise roles of these heme-binding proteins in virulence have not yet been well described; in particular, little is known about the function of Csa2 in heme-iron uptake. Therefore, we aimed to clarify the involvement of Csa2 in iron acquisition during hyphal growth in C. albicans.
A csa2Δ/Δ mutant, previously described as Δorf19.3117, and a triple-auxotrophic strain, BWP17, complemented with plasmid CIp30, which was used as the wild-type control in all experiments, were kindly provided by Professor B. Hube of Hans Knoell Institute, Germany (Zakikhany et al., 2007) . A csa2Δ/Δ::CSA2 complemented strain was constructed by introducing the wild-type allele of the CSA2 gene into the RP10 locus of the csa2Δ/Δ mutant by using the CIp10 plasmid; the integration was verified by means of polymerase chain reaction and DNA sequencing analyses.
Iron-restricted culture conditions were used as described (Weissman et al., 2008) . Yeast cells were cultured at 30°C in YPD medium (1% yeast extract, 2% peptone, and 2% glucose per liter) supplemented with 1 mM ferrozine (an iron chelator) to elicit iron starvation. To induce switching to the hyphal form, yeast cells (1  10 4 cells/mL) were transferred to RPMI 1640 medium in which free iron had been removed by the addition of 100 g/mL of apotransferrin, and then cultured for 16 to 24 h under 5% CO 2 at 37°C.
Preliminary experiments showed that the growth of all three strains in RPMI 1640 medium was similar. All three strains also exhibited similar dose-dependent growth inhibition by chelating free iron, which is essential for growth, when incubated with a series of apotransferrin dilutions in RPMI 1640 medium. Growth was totally inhibited by the addition of 100 g/mL apotransferrin; therefore, this concentration of apotransferrin was used to chelate the free iron in the culture medium. Hyphal growth morphology was confirmed microscopically and growth was assessed by means of a crystal violet (CV)-staining assay.
Viable Candida hyphal cells were quantified by measuring the photometric absorbance of the Candida-bound CV extract at a wavelength of 590 nm (Abe et al., 1994) . Next, we examined whether C. albicans was able to utilize hemoglobin as an iron source under iron-restricted conditions and whether the addition of human hemoglobin to the environment was able to rescue impaired hyphal growth (Fig. 1b) . With the addition of human hemoglobin, hyphal growth was restored in the wild-type and csa2Δ/Δ::CSA2
complemented strain but only partially so in the csa2Δ/Δ mutant. The csa2Δ/Δ mutant grew at approximately one-third the rate of the wild-type strain when a high concentration of human hemoglobin was the sole source of iron. These results indicate that Csa2 is involved in the utilization of human hemoglobin as a source of iron. Interestingly, deletion of CSA2 did not fully attenuate growth, implying that additional genes and mechanisms are involved in the exploitation of environmental iron.
In a hemoglobin binding assay, to quantify the adherent C. albicans, we used hemoglobin-sensitized tubes that were prepared by incubation overnight at 37°C with human hemoglobin in Ca 2+ -and Mg 2+ -free phosphate-buffered saline, as described previously (Tanaka et al., 1997) . We observed attenuation of the capacity of the csa2Δ/Δ mutant to bind human hemoglobin compared with that of wild-type C. albicans (Fig. 1c) .
We also examined whether Csa2 was involved in hemolysis by measuring the hemolytic activity of the C. albicans culture supernatant. Culture supernatants from the three strains of C. albicans were mixed with human erythrocytes and incubated for 12 to 72 h at 37°C, and the hemolytic activity was measured by the absorption at 405 nm (Tanaka et al., 1997) . No significant differences in hemolytic activity between the culture supernatant of wild-type C.
albicans and that of the csa2Δ/Δ mutant were observed (data not shown), indicating that Csa2
was not involved in hemolysis.
Taken together, our results show that Csa2 is involved in iron utilization and hemoglobin binding, and that Csa2 binds to hemoglobin before presenting it to other heme-binding proteins.
Although the functions of the proteins in the Rbt5 family that possess the conserved CFEM are largely unknown, they are suspected to play important roles in fungal pathogenesis (Kulkarni et al., 2003) . Sorgo et al. (2013) used mass spectrometry to characterize the dynamics of the response of the C. albicans cell-wall proteome to iron starvation, and in particular the remarkable changes in the levels of the GPI-modified members of the Rbt5 family; their results suggest that the CFEM domain is responsible for the heme-binding properties of these proteins. Furthermore, secretome analyses have shown that the level of Csa2 increases under conditions of iron starvation (Sorgo et al., 2013) . Interestingly, in addition to using hemoglobin as an iron source, C. albicans also uses hemoglobin as a signaling molecule to alter gene expression and induce adhesion to several extracellular matrix proteins (Pendrak & Roberts, 2007) .
Further studies are required to delineate the molecular basis of iron uptake by C. albicans.
Our results suggest that members of the Rbt5 protein family collaborate in iron acquisition and that Csa2 may bind to hemoglobin before presenting it to other heme-binding proteins.
Our group is currently attempting to characterize the involvement of Csa2 in iron acquisition and virulence. In conclusion, our findings suggest that Csa2 is involved in the utilization of iron from human hemoglobin during hyphal growth in C. albicans. 
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